TET1 protein was initially described as a fusion partner of the mixed lineage leukemia (MLL) gene in acute myeloid leukemia (AML) as well as pediatric leukemias bearing the t(10:11)(q22;q23) translocation [1–3]. This evidence concerns the gene KMT2A and leukemia.